BCL2L12: a multiply spliced gene with independent prognostic significance in breast cancer.

Conclusions BCL2L12 v.1, v.2, v.4 are aberrantly expressed in BC. Their expressional analysis by cost-effective molecular methods could provide a novel molecular tool for BC management.
PMID: 30325729 [PubMed - as supplied by publisher]

Source: Clinical Genitourinary Cancer - October 16, 2018 Category: Cancer & Oncology Authors: Kladi-Skandali A, Sideris DC, Scorilas A Tags: Clin Chem Lab Med Source Type: research